Print Agenda: 2025 Avoca Quality Consortium Summit

Tuesday, May 13, 2025
10:00 AM - 10:10 AM (EDT)	Navigating the Future: The Compass to Next-Generation Clinical Trials
10:10 AM - 10:30 AM (EDT)	Opening Remarks from Jennifer Sheller, Senior Vice President, Head of Global Clinical Trial Operations, Merck • Jennifer Sheller - Senior Vice President, Head of Global Clinical Trial Operations - Merck
10:30 AM - 11:15 AM (EDT)	Panel Discussion: Wisdom - The True North of Clinical Quality • Aramy R. Forrest - Sr. Director Project Management and Clinical Affairs, Development Innovations - Sarah Cannon Research Institute • David Fryrear, MS - Chief Quality Officer - Astellas • Jennifer Sheller - Senior Vice President, Head of Global Clinical Trial Operations - Merck • Corey Alexander, MBA - Global Head, GCP Inspections and Process Quality, RDQ CQA - Novartis (Moderator)
11:15 AM - 11:30 AM (EDT)	Navigating the AQC Compass • Sam Srivastava - CEO - WCG
11:30 AM - 12:15 PM (EDT)	Panel Discussion: Efficiency - Sunrise of Clinical Innovation • Dominic De Bellis, PhD - Executive Director, Artificial Intelligence Strategy & Operations Lead, Medical Writing & Disclosure \| Global Clinical Trial Operations - Merck • Dawn East - Associate Vice President – Global Medicine Quality - Eli Lilly and Company • Gaurav Josan - Senior Vice President, Research & Development - Clario • Jill Johnston, CCRA, CPM - Chief Innovation Officer - WCG (Moderator)
12:15 PM - 12:30 PM (EDT)	2025 Avoca Industry Survey Preliminary Results: ICH E6 (R3) Implementation
12:30 PM - 1:00 PM (EDT)	Break: Experiences related to clinical trials
1:00 PM - 1:45 PM (EDT)	Option 1: Applied Wisdom • Katie Delaney, DHA, MBA - Subject Matter Expert, AQC - Avoca, A WCG Company • Irene Michas, PhD, MSc - Senior Consultant - Avoca, A WCG Company	Option 2: Applied Efficiency • Kevin Richards - Head of Quality Investigations and Analytics - AstraZeneca • Mark Volk - Associate Director, Quality Investigations & Analytics, Clinical Operations, R&D - AstraZeneca
1:45 PM (EDT)	Day 1 Adjourn
Wednesday, May 14, 2025
10:00 AM - 10:05 AM (EDT)	Welcome
10:05 AM - 10:10 AM (EDT)	Opening Remarks
10:10 AM - 10:30 AM (EDT)	Resilience Personified - A Patient Story • Katie Doble - Vice President - IQ Clarity
10:30 AM - 11:15 AM (EDT)	Panel Discussion: Resilience - The Bedrock of Sustainability • Rachel Dossman - Director, Clinical Process Compliance, Clinical Development Operations - AbbVie • Saubiya Kidwai - Vice President - PPD/Thermo Fisher • Carly Santer, PhD - Strategic Initiatives Project Leader & Sustainability Activator - Bayer • Michelle Webb - Vice President, Avoca Quality Consortium - Avoca, A WCG Company (Moderator)
11:15 AM - 12:00 PM (EDT)	Panel Discussion: Integrity - The Horizon of Trust • Lauri Befus - Vice President of Operations - M3 Wake Research • Mitchell Katz, PhD - Senior Vice President, Global Clinical Operations - Kyowa Kirin • Kellie MacLeod - Executive Vice President, Global Quality Assurance - Worldwide Clinical Trials • Jean Sposaro - Director, Global Clinical Trial Industry Collaborations, Global Drug Development Operations - Bristol Myers Squibb • Brant Nicks - Senior Vice President, Clinical Solutions & Strategic Partnering - WCG (Moderator)
12:00 PM - 12:30 PM (EDT)	Break: Quiz
12:30 PM - 1:30 PM (EDT)	Option 1: Applied Resilience • Karen Harvey - Senior Director, Avoca Quality Consortium - Avoca, A WCG Company	Option 2: Applied Integrity • Trevor Cole, BHS, MBA-HCM-PM, CCRC, PMP, RN - Director - Avoca, A WCG Company
1:30 PM (EDT)	Meeting Adjourn